Joe Kiani Co-Founder Masimo Corp. The latest legal battle between Irvine-based medical device maker Masimo Corp. and Apple ...

Shares of Masimo Co. (NASDAQ:MASI – Get Free Report) have received an average rating of “Moderate Buy” from the seven ...

Apple and Masimo's patent and trade secret dispute has intensified through lawsuits as Apple defends its innovations and ...

Apple and Masimo are back in a California court this week for a bench trial that will see Masimo arguing that Apple illegally ...

Masimo delivered Q3 results that mostly aligned with guidance, yet it faces challenges in its non-healthcare segment.

Executives said the patient monitoring company’s consumer business will likely become a discontinued operation if it is not ...

We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...

Last week, the Nasdaq Composite, the S&P 500 and the Dow Jones Industrial Average climbed 5.7%, 4.7% and 4.6%, respectively.

Masimo Corp.'s attorneys are betting that evidence of a “deep mind meld” between a Masimo co-founder and a key employee hired ...

Masimo Corp (MASI) reports robust healthcare revenue growth and improved margins, while navigating non-healthcare segment ...

MAMO sees a 30.7% increase in non-GAAP operating income in Q3 2024. Healthcare segment revenues increase 11.5%, driving ...

Masimo (Nasdaq:MASI) shares ticked up before hours today on third-quarter results that came in ahead of the consensus ...